Paolo Gallipoli

3.4k citations
41 papers · 1.1k indexed · h-index 15
Topics
Acute Myeloid Leukemia Research (19 papers)Chronic Myeloid Leukemia Treatments (10 papers)Histone Deacetylase Inhibitors Research (7 papers)

In The Last Decade

Paolo Gallipoli

40 papers receiving 1.1k citations

Peers

Paolo Gallipoli
Comparison fields: 5 of 91
  • Hematology 530
  • Molecular Biology 498
  • Genetics 258
  • Cellular and Molecular Neuroscience 174
  • Oncology 139
Replace Jacques Rochette with:
Jacques Rochette France
Curtis R. Kelly United States
Delphine Bacq France
Judith Asselin United Kingdom
Eloy Cuadrado Spain
Peter Wonerow Germany
Eva Pipili‐Synetos Greece
Paola Cucchi Italy
Masakazu Fujiwara Japan
Paolo Gallipoli relative to Jacques Rochette France Jacques Rochette's profile →
Citations per field
00.5×5.6×
Jacques Rochette · 1×
Citations per year

Countries citing papers authored by Paolo Gallipoli

Since Specialization
Citations

This map shows the geographic impact of Paolo Gallipoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Gallipoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Gallipoli more than expected).

Fields of papers citing papers by Paolo Gallipoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Gallipoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Gallipoli. The network helps show where Paolo Gallipoli may publish in the future.

Co-authorship network of co-authors of Paolo Gallipoli

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Gallipoli. A scholar is included among the top collaborators of Paolo Gallipoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Gallipoli. Paolo Gallipoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 2
4 14
5 3
6 2
7 39
8 8
9 101
10 20
11 99
12 56
13 4
14 68
15 15
16 29
17 4
18 4
19 11
20 5

About Paolo Gallipoli

Paolo Gallipoli is a scholar working on Hematology, Genetics and Immunology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Hematology (530 citations), Genetics (258 citations) and Internal Medicine (36 citations). Paolo Gallipoli has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Janet A. Clark, Susan Amara, Ariel Y. Deutch, Tessa L. Holyoake, Brian J.P. Huntly, Heather G. Jørgensen, George Giotopoulos, Roberto Castelli, Lisa Hopcroft and Ravi Bhatia. Their work appears in journals such as Nature Communications, Neuron and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026